[go: up one dir, main page]

IL153426A0 - Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies - Google Patents

Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies

Info

Publication number
IL153426A0
IL153426A0 IL15342601A IL15342601A IL153426A0 IL 153426 A0 IL153426 A0 IL 153426A0 IL 15342601 A IL15342601 A IL 15342601A IL 15342601 A IL15342601 A IL 15342601A IL 153426 A0 IL153426 A0 IL 153426A0
Authority
IL
Israel
Prior art keywords
neuropathies
peripheral
vascular diseases
autonomic
treating
Prior art date
Application number
IL15342601A
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL153426A0 publication Critical patent/IL153426A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL15342601A 2000-06-30 2001-06-29 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies IL153426A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21506500P 2000-06-30 2000-06-30
US21902900P 2000-07-18 2000-07-18
PCT/US2001/041202 WO2002002118A1 (en) 2000-06-30 2001-06-29 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies

Publications (1)

Publication Number Publication Date
IL153426A0 true IL153426A0 (en) 2003-07-06

Family

ID=26909649

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15342601A IL153426A0 (en) 2000-06-30 2001-06-29 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies

Country Status (13)

Country Link
EP (1) EP1303279A1 (en)
JP (1) JP2004511433A (en)
KR (1) KR20030047907A (en)
CN (1) CN1440287A (en)
AU (1) AU2001279275A1 (en)
BR (1) BR0112100A (en)
CA (1) CA2414352A1 (en)
HU (1) HUP0301451A3 (en)
IL (1) IL153426A0 (en)
MX (1) MXPA03000033A (en)
NZ (1) NZ523108A (en)
PL (1) PL365565A1 (en)
WO (1) WO2002002118A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0020588D0 (en) * 2000-08-21 2000-10-11 Pfizer Ltd Treatment of wounds
US8133903B2 (en) 2003-10-21 2012-03-13 Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases
MXPA05009242A (en) * 2003-03-17 2006-04-18 Pfizer Prod Inc Treatment of type 1 diabetes with pde5 inhibitors.
FR2877013A1 (en) * 2004-10-27 2006-04-28 Assist Publ Hopitaux De Paris INDENTIFICATION OF A JAK2 MUTATION INVOLVED IN THE VAQUEZ POLYGLOBULIA
EP1838319B1 (en) * 2005-01-07 2018-03-07 The Johns Hopkins University Pde5 inhibitor compositions and methods for immunotherapy
MX2017016930A (en) * 2017-12-19 2019-06-20 Malesil Research & Tech Llc Method of treatment of diabetic foot ulcers.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043252A (en) * 1997-05-05 2000-03-28 Icos Corporation Carboline derivatives
US6075028A (en) * 1999-09-23 2000-06-13 Graham; Richard Method of treating Tourette's syndrome and related CNS disorders

Also Published As

Publication number Publication date
AU2001279275A1 (en) 2002-01-14
EP1303279A1 (en) 2003-04-23
WO2002002118A1 (en) 2002-01-10
NZ523108A (en) 2005-04-29
BR0112100A (en) 2003-05-20
CA2414352A1 (en) 2002-01-10
HUP0301451A3 (en) 2004-10-28
MXPA03000033A (en) 2003-09-25
JP2004511433A (en) 2004-04-15
CN1440287A (en) 2003-09-03
PL365565A1 (en) 2005-01-10
HUP0301451A2 (en) 2003-09-29
KR20030047907A (en) 2003-06-18

Similar Documents

Publication Publication Date Title
IL162505A0 (en) Method for treatment of peripheral neural and vascular ailments
IL162447A0 (en) Methods for slowing senescence and treating and preventing diseases associated with senescence
AU7186501A (en) Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
AU2003278775A8 (en) Porifera-based therapeutic compositions for treating and preventing skin diseases
AU2002367535A8 (en) Diagnosis and treatment of vascular disease
AU8136801A (en) Methods of preventing or treating diseases and conditions using complex carbohydrates
AU8878801A (en) Agent and method of prevention and treatment of cancer in animals
MXPA03008582A (en) Agents and methods for treatment of cancer.
MXPA03003741A (en) Methods and compositions for the treatment of diseases of the eye.
AU5754701A (en) Method of using cox-2 inhibitors in the treatment and prevention of ocular cox-2mediated disorders
IL138692A0 (en) Treatment and prevention of vascular disease
IL148202A0 (en) Copolymers and methods of treating prion-related diseases
EP1425027A4 (en) Method and composition for treatment of wounds and burns
AU1794801A (en) Method for treatment and prevention of physiological shock
IL153426A0 (en) Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies
GB0115707D0 (en) Treatment and prevention of lipodermatosclerosis
GB2360453B (en) Treatment of skin conditions
MXPA03004449A (en) Cosmetic method of treating skin.
AU6970101A (en) Method for treatment and prevention of mastitis
GB0101146D0 (en) Treatment of skin conditions
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
WO2005056054A3 (en) METHODS OF INHIBITING APOPTOSIS USING INDUCERS OF NF-κB
EP1303281A4 (en) Methods of treatment
GB0030865D0 (en) Treatment and prevention of disease
GB0016197D0 (en) Treatment and prevention of disease